Australian courts uphold groundbreaking proceedings against Johnson & Johnson, Health News and ET Health World

An Australian court upheld a groundbreaking class action against Johnson & Johnson on Friday for “faulty” marketing of pelvic mesh implants, with thousands of costly setbacks for a major U.S. pharmaceutical company. Paved the way for women to receive compensation.

Johnson & Johnson has appealed a 2019 ruling that the company was found guilty of “negligence” marketing and “fraud” while supplying thousands of pelvic meshes in Australia.

Victims said the mesh designed to support the weakened muscles that support the pelvic organs caused disastrous side effects such as incontinence, infections, and chronic pain.

“Risks are not important and are known and, with the consent of the respondents themselves, can cause serious and serious harm,” the judge said in the first decision.

A committee of three judges in federal court dismissed the appeal on Friday, “confirming that these women have the right to compensate for the losses and life-changing complications they suffered as a result of these implants.” Said. Plaintiff’s lawyer, Rebecca Yankascus.

Shine Royers, who led the class action proceedings, said he would vigorously pursue compensation claims, which could possibly amount to hundreds of millions of dollars.

The three women involved in the 2019 proceedings were awarded compensation ranging from A $ 556,000 to A $ 1.28 million (US $ 430,000 to $ 1 million).

The remaining members of the class proceedings will now bring their own individual claims to court.

In response to Friday’s ruling, Johnson & Johnson said, “I sympathize with all women who have experienced complications,” but will consider the court’s decision and “consider its options.”

With more than 2 million women embedding mesh products in their bodies worldwide, the Australian ruling is just one of a series in the world.

Earlier last year, a California judge ordered Johnson & Johnson to pay $ 344 million for false and fraudulent marketing of pelvic mesh products used by tens of thousands of women in the state.

The company settled a claim similar to Washington for $ 9.9 million, and the coalition of the other 42 states settled for $ 117 million.

Back to top button